Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 172,000 | 85,000 | 70,000 | 196,000 | 203,000 |
| Marketable Securities | 513,000 | 894,000 | 697,000 | 414,000 | 287,000 |
| Receivables | 1,058,000 | 963,000 | 882,000 | 880,000 | 679,000 |
| Inventories | 832,000 | 763,000 | 592,000 | 671,000 | 621,000 |
| Other current assets | 353,000 | 271,000 | 277,000 | 236,000 | 237,000 |
| TOTAL | $2,928,000 | $2,976,000 | $2,518,000 | $2,397,000 | $2,027,000 |
| Non-Current Assets | |||||
| PPE Net | 1,144,000 | 923,000 | 809,000 | 819,000 | 781,000 |
| Investments And Advances | 178,000 | 63,000 | 65,000 | 105,000 | 114,000 |
| Intangibles | 1,272,000 | 494,000 | 427,000 | 417,000 | 549,000 |
| Other Non-Current Assets | 250,000 | 194,000 | 98,000 | 121,000 | 158,000 |
| TOTAL | $2,844,000 | $1,674,000 | $1,399,000 | $1,462,000 | $1,602,000 |
| Total Assets | $5,772,000 | $4,650,000 | $3,916,000 | $3,860,000 | $3,630,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 455,000 | 169,000 | 148,000 | 370,000 | 328,000 |
| Accounts payable and accrued liabilities | 417,000 | 371,000 | 322,000 | 337,000 | 325,000 |
| Other current liabilities | 620,000 | 586,000 | 548,000 | 510,000 | 468,000 |
| TOTAL | $1,527,000 | $1,152,000 | $1,044,000 | $1,239,000 | $1,140,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,000 | 72,000 | 16,000 | 76,000 | 86,000 |
| Other Non-Current Liabilities | 33,000 | 49,000 | 36,000 | 33,000 | 33,000 |
| TOTAL | $298,000 | $132,000 | $62,000 | $110,000 | $124,000 |
| Total Liabilities | $1,825,000 | $1,284,000 | $1,106,000 | $1,348,000 | $1,264,000 |
| Shareholders' Equity | |||||
| Common Shares | 10,000 | 10,000 | 10,000 | 11,000 | 11,000 |
| Retained earnings | 3,697,000 | 3,183,000 | 2,623,000 | 2,316,000 | 2,133,000 |
| Other shareholders' equity | 137,000 | 56,000 | 74,000 | 83,000 | 127,000 |
| TOTAL | $3,947,000 | $3,366,000 | $2,810,000 | $2,511,000 | $2,366,000 |
| Total Liabilities And Equity | $5,772,000 | $4,650,000 | $3,916,000 | $3,859,000 | $3,630,000 |